[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100537855":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":31,"locations":36,"responsibleParty":91,"collaborators":93,"id":98,"slug":99,"hasResults":100,"nctId":101,"briefTitle":102,"officialTitle":103,"acronym":18,"eligibilityCriteria":104,"healthyVolunteers":100,"sex":105,"minAge":18,"maxAge":106,"enrollmentInfo":107,"targetDuration":18,"studyType":110,"phases":111,"briefSummary":113,"conditions":114,"keywords":119,"overallStatus":39,"whyStopped":18,"lastUpdateSubmitDate":120,"lastUpdatePostDateStruct":121,"startDateStruct":124,"completionDateStruct":126,"leadSponsor":128,"locationsCount":129},{"fullName":5,"class":6},"Dana-Farber Cancer Institute","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"PediRISE Program Group","EXPERIMENTAL","Participants will be randomized in a 1:1 fashion and will be stratified by site. Participant parents will complete:\n\n* Baseline survey in-person, by telephone, or virtually.\n* PediRISE program orientation with study team member, in-person or virtual.\n* Optional meeting with certified benefits counselor.\n* Receive fixed funds twice a month for 6 months.\n* Standard supportive care from social worker and\u002For resource specialist to identify and discuss available resources.\n* End of study survey.",[13],"Behavioral: PediRISE Resource Program",{"label":15,"type":16,"description":17,"interventionNames":18},"Usual Care Group","NO_INTERVENTION","Participants will be randomized in a 1:1 fashion and will be stratified by site. Participant parents will complete:\n\n* Baseline survey in-person, by telephone, or virtually, and orientation with study team member.\n* Standard supportive care from social worker and\u002For resource specialist to identify and discuss available resources.\n* End of study survey.",null,[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"BEHAVIORAL","PediRISE Resource Program","A centrally administered, income-poverty targeted intervention that includes twice-monthly direct provision of unrestricted cash transfers along with benefits counseling to mitigate the risk of loss of means-tested benefits. Funds will be dispersed to families via provided debit card or through personal banking, PayPal, or Venmo.",[9],[26],"PediRISE",[28],{"name":29,"affiliation":5,"role":30},"Kira Bona, MD, MPH","PRINCIPAL_INVESTIGATOR",[32],{"name":29,"role":33,"phone":34,"phoneExt":18,"email":35},"CONTACT","617-632-4688","Kira_Bona@dfci.harvard.edu",[37,56,69,77],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"University of California San Francisco","RECRUITING","San Francisco","California","94143","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-122.41942,37.77493,{"lat":49,"lon":48},[52],{"name":53,"role":33,"phone":54,"phoneExt":18,"email":55},"Lena Winestone, MD, MPH","(877) 822-4453","lena.winestone@ucsf.edu",{"facility":57,"status":39,"city":58,"state":59,"zip":60,"country":43,"countryCode":44,"cosmosGeoPoint":61,"geoPoint":65,"contacts":66},"Boston Children's Hospital","Boston","Massachusetts","02215",{"type":46,"coordinates":62},[63,64],-71.05977,42.35843,{"lat":64,"lon":63},[67,68],{"name":29,"role":33,"phone":34,"phoneExt":18,"email":35},{"name":29,"role":30,"phone":18,"phoneExt":18,"email":18},{"facility":70,"status":39,"city":58,"state":59,"zip":60,"country":43,"countryCode":44,"cosmosGeoPoint":71,"geoPoint":73,"contacts":74},"Dana Farber Cancer Institute",{"type":46,"coordinates":72},[63,64],{"lat":64,"lon":63},[75,76],{"name":29,"role":33,"phone":34,"phoneExt":18,"email":35},{"name":29,"role":30,"phone":18,"phoneExt":18,"email":18},{"facility":78,"status":39,"city":79,"state":79,"zip":80,"country":43,"countryCode":44,"cosmosGeoPoint":81,"geoPoint":85,"contacts":86},"Columbia University Medical Center","New York","10032",{"type":46,"coordinates":82},[83,84],-74.00597,40.71427,{"lat":84,"lon":83},[87],{"name":88,"role":33,"phone":89,"phoneExt":18,"email":90},"Justine Kahn, MD","(212) 305-9770","jk2034@cumc.columbia.edu",{"type":30,"investigatorFullName":29,"investigatorTitle":92,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Principal Investigator",[94,96],{"name":95,"class":6},"American Cancer Society, Inc.",{"name":97,"class":6},"Children's Cancer Research Fund","100537855","pedirise-feasibility-100537855",false,"NCT06283251","PediRISE Feasibility","Pilot Randomized Pediatric RISE (Resource Intervention to Support Equity) Feasibility Study","Inclusion Criteria\n\nCohort 1: Poverty-exposed children with cancer receiving front-line cancer-directed therapy\n\n1. Child diagnosed with de novo cancer\n2. Child has established care at a study site and initiated cancer directed therapy in the prior 2-months\n3. Child planned to receive at least 4-months of cancer-directed therapy at study site from time of diagnosis per initial cancer treatment plan\n4. Child is \\\u003C18 years at time of enrollment\n5. Parent\u002Fguardian screened positive for self-reported low-income (\\\u003C200% FPL)\n6. Family primary residence in CA, CT, MA, ME, NH, NJ, NY or RI\n7. Provider approval for permission to approach\n\nCohort 2: Poverty-exposed children with cancer undergoing HSCT\n\n1. Child undergoing allogeneic HSCT for treatment of cancer\n2. Child has established care at a study site and is between 30 days prior to start of planned conditioning through day +7 of HSCT at time of enrollment\n3. Child planned to receive follow-up care after discharge for HSCT at study site\n4. Child is \\\u003C18 years at the time of enrollment\n5. Parent\u002Fguardian screen positive for self-reported low-income (\\\u003C200% FPL)\n6. Family primary residence in CA, CT, MA, ME, NH, NJ, NY or RI\n7. Provider approval for permission to approach\n\nExclusion Criteria\n\nCohort 1: Poverty-exposed children with cancer receiving front-line cancer-directed therapy\n\n1. Planned transfer of child to a non-DFCI or non-Columbia facility for cancer-directed therapy\n2. Foreign national family receiving care as an Embassy-pay patient\n3. Child is enrolled on embedded correlative health equity aims of open or upcoming clinical drug trials which are powered on descriptive parent-reported poverty data (e.g. AALL1731, DFCI 25-001). Co-enrollment on a poverty intervention study would confound the specified endpoints of these open trial correlative studies\n4. Child or household member receiving SSI\n\nCohort 2: Poverty-exposed children with cancer undergoing HSCT\n\n1. Planned transfer of child to a non-DFCI, non-Columbia, or non UCSF facility for cancer-directed therapy\n2. Foreign national family receiving care as an Embassy-pay patient\n3. Child is enrolled on embedded correlative health equity aims of open or upcoming clinical drug trials which are powered on descriptive parent-reported poverty data (e.g. AALL1731, DFCI 25-001). Co-enrollment on a poverty intervention study would confound the specified endpoints of these open trial correlative studies\n4. Child previously received RISE intervention\n5. Child or household member receiving SSI","ALL","17 Years",{"count":108,"type":109},40,"ESTIMATED","INTERVENTIONAL",[112],"NA","The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a study about the PediRISE program, including a 50-50 chance of receiving standard usual care, and a 50-50 chance of receiving the PediRISE support program.\n\nThe names of the study groups in this research study are:\n\n* PediRISE Program Group\n* Usual Care Group",[115,116,117,118],"Pediatric Cancer","Financial Stress","Financial Hardship","Disparities",[115,116,117,118],"2026-02-09",{"date":122,"type":123},"2026-02-10","ACTUAL",{"date":125,"type":123},"2024-05-15",{"date":127,"type":109},"2027-06-30",{"name":5,"class":6},4]